Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (10)

2022

  1. Venous Thromboembolism In Cancer Patients: “From Evidence to Care”

    Clinical and Applied Thrombosis/Hemostasis, Vol. 28

2021

  1. Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

    BMC Cancer, Vol. 21, Núm. 1

2020

  1. Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram

    Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 351-359

  2. First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial

    Clinical and Translational Oncology, Vol. 22, Núm. 4, pp. 495-502

2018

  1. Single-Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial)

    Oncologist, Vol. 23, Núm. 11, pp. 1271-e128

2015

  1. Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer

    Cancer Chemotherapy and Pharmacology, Vol. 76, Núm. 4, pp. 731-737

2010

  1. A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

    British Journal of Cancer, Vol. 103, Núm. 10, pp. 1536-1541

  2. Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery

    Cancer Chemotherapy and Pharmacology, Vol. 66, Núm. 3, pp. 567-573

  3. Efficacy of epoetin-beta 30,000 IU/week in correcting anaemia in patients with gastrointestinal tumours subjected to concomitant chemoradiotherapy

    Clinical and Translational Oncology, Vol. 12, Núm. 12, pp. 843-848

2007

  1. Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: A phase II study of the Galician Lung Cancer Group (GGCP 013-02)

    Anti-Cancer Drugs, Vol. 18, Núm. 10, pp. 1201-1206